NASHVILLE, Tenn., Oct. 28 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that high unemployment rates in North Carolina will continue to dictate decreasing commercial health plan enrollment rates and rising Medicaid enrollment rates. However, according to the Carolinas Health Plan Analysis, there is less state funding available to deal with increasing Medicaid enrollment.
The report finds that in order to compensate for this, the state is putting cost-saving measures in place. North Carolina has moved to decrease its drug spending by utilizing a preferred drug list, which will confine drug choices to clinically effective generics and lower-cost alternatives whenever possible. Branded drugs will only be available to recipients on a prior-approval basis. In addition, state legislators have agreed to allow the North Carolina Department of Health and Human Services to enter a multistate purchasing pool to leverage drug rebates and discounts from pharmaceutical companies.
"Compared to other states, North Carolina is late to the table with a preferred drug list," states Jan Shuxteau, market analyst with HealthLeaders-InterStudy. "Pharmaceutical companies will face barriers in the state with prior authorizations and an emphasis on generics. In addition, expect the Department of Health and Human Services to negotiate directly with pharma companies and contract with a pharmacy benefit manager for negotiated discounts and rebates."
Other topics highlighted in the recent Carolinas Health Plan Analysis include:
- How South Carolina is responding to its increasing Medicaid enrollment.
- Blue Cross and Blue Shield of North Carolina, the largest plan in the state, and its plan to cut administrative costs by 20 percent.
- The move by Humana to add the Carolinas HealthCare System to its provider network.
Why Pharmaceutical Company Managed Markets Teams Need Health Plan Analysis
Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly, Health Plan Analysis provides a detailed look at plan design and financials, as well as information about mergers, legislation and other influencers driving healthcare in a particular region.
HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com .
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.